Table 3. Cox regression analysis for PFS and OS for all the patients with DLBCL (N=169).
| Factors | PFS | OS | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | |
| PET(0)-BMI(+) | 3.96 (2.38–6.59) | <0.001 | - | - | 6.73 (3.40–13.34) | <0.001 | 2.90 (1.21–6.96) | 0.017 |
| BMB(0)-BMI(+) | 4.49 (2.53–7.98) | <0.001 | - | - | 6.24 (3.06–12.73) | <0.001 | - | - |
| IPI > 2 | 7.27 (4.19–12.63) | <0.001 | 3.12 (1.31-7.47) | 0.010 | 9.02 (3.94–20.61) | <0.001 | 3.62 (1.01–13.03) | 0.049 |
| Age > 60 years | 1.61 (0.98–2.64) | 0.060 | 1.18 (0.61–2.27) | 0.627 | ||||
| Stage III or IV | 6.08 (2.77–13.36) | <0.001 | - | - | 6.78 (2.08–22.12) | 0.002 | - | - |
| ECOG 2−4 | 2.79 (1.65–4.71) | <0.001 | 1.97 (1.12-3.47) | 0.019 | 3.39 (1.75–6.55) | <0.001 | - | - |
| LDH>ULN | 4.68 (2.82–7.78) | <0.001 | - | - | 4.31 (1.96–9.48) | <0.001 | - | - |
| Extranodal site > 1 | 3.15 (1.91–5.18) | <0.001 | - | - | 3.04 (1.58–5.86) | 0.001 | - | - |